CLINICAL_TRIALS
trial_result
· 2022-06-01
Clinical Trial Update: A Study of Durvalumab (MEDI4736) in Esophageal Cancer [Phase 2]
Summary
Phase 2 trial of durvalumab in esophageal cancer has been completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shadia Jalal, MD | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-06-01